News stories about K2M Group (NASDAQ:KTWO) have trended positive on Wednesday, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. K2M Group earned a coverage optimism score of 0.39 on Accern’s scale. Accern also assigned news coverage about the medical device company an impact score of 46.5109071610072 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
K2M Group (NASDAQ:KTWO) opened at $19.10 on Wednesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 3.06 and a quick ratio of 1.67. K2M Group has a one year low of $16.44 and a one year high of $25.99. The company has a market cap of $837.54, a PE ratio of -19.69 and a beta of 1.47.
Several brokerages have recently weighed in on KTWO. BidaskClub raised shares of K2M Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 10th. Piper Jaffray Companies restated a “buy” rating and issued a $28.00 price target on shares of K2M Group in a research note on Friday, November 3rd. Needham & Company LLC decreased their price target on shares of K2M Group from $27.00 to $26.00 and set a “strong-buy” rating on the stock in a research note on Thursday, November 2nd. Oppenheimer restated a “buy” rating and issued a $24.00 price target on shares of K2M Group in a research note on Friday, November 10th. Finally, Barclays restated a “buy” rating and issued a $25.00 price target on shares of K2M Group in a research note on Tuesday, January 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and nine have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $24.50.
ILLEGAL ACTIVITY WARNING: This news story was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.chaffeybreeze.com/2018/02/21/k2m-group-ktwo-earning-favorable-news-coverage-analysis-shows.html.
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.